Article Commentary: Motes,Beams and Evidence-Based Practice

Fisher P , van Haselen R , Hardy K , Berkovitz S , McCarney R . Effectiveness gaps: a new concept for evaluating health service and research needs applied to complementary and alternative medicine. J Alt Comp Med 2004; 10: 627–32

See http://guidance.nice.org.uk/CG88 (last checked 17 June 2009)

Vickers A , Smith C . Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001957

Kassab S , Cummings M , Berkovitz S , van Haselen R , Fisher P . Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD004845

Taylor MA , Reilly D , Llewellyn-Jones RH , McSharry C , Aitchison TC . Randomised controlled trials of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ 2000; 321: 471–6

Barnes J , Resch K-L , Ernst E . Homeopathy for postoperative ileus? A meta-analysis. J Clinical Gastroenterology 1997; 25: 628–33

Connors AF Jr. , Speroff T , Dawson NV The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996; 276: 889–97

Grodstein F , Stampfer MJ , Manson JE Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–61

Katz DL , Williams AL , Girard C The evidence base for complementary and alternative medicine: methods of Evidence Mapping with application to CAM. Altern Ther Health Med 2003; 9: 22–30

Thorne S , Best A , Balon J , Kelner M , Rickhi B . Ethical dimensions in the borderland between conventional and complementary/alternative medicine. J Altern Complement Med 2002; 8: 907–15

Vohra S , Cohen MH . Ethics of complementary and alternative medicine use in children. Pediatr Clin North Am 2007; 54: 875–84

Kaptchuk TJ , Miller FG . Viewpoint: what is the best and most ethical model for the relationship between mainstream and alternative medicine: opposition, integration, or pluralism? Acad Med 2005; 80: 286–90

BMJ Clinical Evidence. See http://clinicalevidence.bmj.com/ceweb/about/knowledge.jsp (last checked 18 June 2009)

See http://www.newyorker.com/reporting/2009/06/01/090601fa_fact_gawande?currentPage=all (last checked 22 June 2009)

Khatta M , Alexander BS , Krichten CM The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med 2000; 132: 636–40

Dargie HJ . Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 2001; 357: 1385–90

Wester K , Jönsson AK , Spigset O , Druid H , Hägg S . Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008; 65: 573–9

Lazarou J , Pomeranz B , Corey P . Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5

Levesque L , Brophy J , Zhang B . The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults. Ann Intern Med 2005; 142: 481–9